MHYS Stock UPDATES Mass Hysteria Ent (MHYS) 0.0004 10/29/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mass Hysteria Ent (MHYS) 0.0004 $MHYS

Prosecutors in NYC indict 8 in stock fraud case
By JAKE PEARSON - AP - Thu Sep 11, 5:49PM CDT
NEW YORK (AP) — Four of eight people charged in a penny stock "pump and dump" scheme that defrauded $290 million from thousands of investors were arraigned on Thursday following a two-year investigation.

Keanu Reeves and Ana De Armas to Star in Gee Malik Linton's Dramatic Thriller "Daughter Of God"
ACCESSWIRE - Tue Sep 09, 4:51AM CDT
HOLLYWOOD, CA / ACCESSWIRE / September 9, 2014 / Mass Hysteria Entertainment Company, Inc. (OTC:MHYS)(PINKSHEETS:MHYS) Keanu Reeves and Ana de Armas will star in Gee Malik Linton's dramatic thriller DAUGHTER OF GOD, it was announced today by Fortitude International. Linton wrote the script and is directing the project, which is scheduled to commence principal photography in November. Fortitude represents international rights and company principal Nadine de Barros has kicked-off sales at the 2014 Toronto International Film Festival.

Keanu Reeves and Ana De Armas to Star in Gee Malik Lintons Dramatic Thriller Daughter Of God
eTeligis - Tue Sep 09, 4:31AM CDT
HOLLYWOOD, CA, United States, via ETELIGIS INC., 09/09/2014 - - Mass Hysteria Entertainment Company, Inc. (OTC:MHYS) (PINKSHEETS:MHYS) Keanu Reeves and Ana de Armas will star in Gee Malik Linton's dramatic thriller DAUGHTER OF GOD, it was announced today by Fortitude International. Linton wrote the script and is directing the project, which is scheduled to commence principal photography in November. Fortitude represents international rights and company principal Nadine de Barros has kicked-off sales at the 2014 Toronto International Film Festival.

Mass Hysteria Entertainment Company is Looking for Dynamic Movies to Finance
ACCESSWIRE - Thu Aug 14, 5:27AM CDT
HOLLYWOOD, CA / ACCESSWIRE / August 14, 2014 / Mass Hysteria Entertainment Company, Inc. (OTC Pink: MHYS) (PINKSHEETS: MHYS), under the new brand name of Remark Pictures is actively looking for theatrical motion pictures that are in need of funding. The Company is currently analyzing scripts and packages with recognizable stars and directors in hopes of entering into negotiations shortly to proceed on a couple of projects for the fall. "Remark's mandate is to build a portfolio of dynamic films," said Daniel Grodnik the Company's CEO. "We're interested in film properties at all stages of development and under select circumstances would consider putting up development money. Our search is focused primarily on dramas and thrillers with established marquee names."

Mass Hysteria Entertainment Changes Company Direction and Intends to Rebrand Under the Name Remark Pictures
ACCESSWIRE - Mon Aug 04, 8:56AM CDT
HOLLYWOOD, CA / ACCESSWIRE / August 4, 2014 / Mass Hysteria Entertainment Company, Inc. (OTCQB: MHYS) has changed its' mandate to become a full fledged financier and producer of theatrical movies under the new brand name of REMARK PICTURES. The Company is proceeding with the name change and will seek a new symbol from FINRA. "This change in direction moves the Company from development stage to operational," said the Company's CEO, Daniel Grodnik. "The independent film business today is red hot for quality content and I believe our credentials, experience and access in Hollywood uniquely position us to become a leader in the space."

Mass Hysteria Entertainment Company's Follow Up CEO letter to Shareholders
PR Newswire - Fri Feb 08, 5:30AM CST
Mass Hysteria Entertainment Company, Inc. (MHYS: OTC Markets) provides a follow up letter to its shareholders from its CEO, Daniel Grodnik.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rosti Group Expands with Alvi Acquisition

Updated Category News Views 139

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 0

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 98

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 57

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 119

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Bybit Expands On-Chain Access: Japanese Equity Focus

Updated Category News Views 71

Bybit's Bold Foray Into Japanese Equities Isn't every trader just itching to talk about Japan these days? Well, Bybit's got your back with its latest maneuvers. The platform is broadening its scope by diving headfirst into Japanese equities with a fresh offering—JPE backed by JX, no less. Bybit's RWA Earn platform isn't sticking to the boring fixed-income strategy...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 109

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Biond's BND-67 Trial: New Hope Against Tumors

Updated Category News Views 55

Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...

Continue Reading
Foundayo Aims to Revolutionize Sleep Apnea Treatment

Updated Category News Views 81

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Continue Reading

Top 5 Most Recently Viewed Articles

Sulliden Mining Capital's Annual Meeting Results Unveiled

Updated Category News Views 159

Sulliden Mining Capital's Annual Meeting Results Unveiled On June 30, 2025, Sulliden Mining Capital Inc. (TSX: SMC) held its Annual and Special Meeting of Shareholders. This event followed the guidelines established by the Toronto Stock Exchange. During the meeting, shareholders engaged in an essential process—electing nominees presented in the management information...

Continue Reading
Ascential Medical's Dynamic Leadership Changes for Growth

Updated Category News Views 348

Leadership Changes at Ascential Medical & Life Sciences Ellen Scipta and Chris Cowen are stepping into pivotal roles as CFO and CCO at Ascential Medical & Life Sciences, while Todd Martensen transitions to the role of CSO. These changes reflect the company's commitment to innovation and strategic growth. Introducing Ellen Scipta: New Chief Financial Officer Ellen Scipta...

Continue Reading
Investors Target Xerox Holdings for Securities Class Action

Updated Category News Views 201

Legal Investigation of Xerox Holdings Corporation Faruqi & Faruqi, LLP, a highly regarded national securities law firm, is currently investigating potential claims involving Xerox Holdings Corporation (NASDAQ: XRX). Investors who have suffered significant financial losses are encouraged to reach out to discuss options available to them. Investor Losses and Legal Options...

Continue Reading
Understanding the Risks of Sharing Back-to-School Photos

Updated Category News Views 240

Understanding the Risks of Sharing Back-to-School Photos As families across the nation prepare for a new school year, there’s an important reminder from experienced investigator and child advocate, Moses Castillo. Before sharing those back-to-school photos on social media, it's crucial to consider the potential dangers associated with such posts. The Hidden Dangers of...

Continue Reading
Intel's Journey: Overcoming Two Decades of Market Struggles

Updated Category News Views 111

Intel's Long Road to Recovery Intel has faced significant challenges over the past two decades. Its stock performance has been lackluster, rising only 2% compared to the NASDAQ 100, which has surged over 1,200%. This stark contrast raises questions about Intel's strategic decisions and future direction. Intel's leadership has stumbled in crucial areas that have allowed...

Continue Reading